Picture of Sun Pharma Advanced Research logo

SPARC — Sun Pharma Advanced Research News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Sun Pharma Advanced Research Gets Orphan Drug Designation From USFDA For SCO-088

July 8 (Reuters) - Sun Pharma Advanced Research Company Ltd
 SPRC.NS :
    * GETS ORPHAN DRUG DESIGNATION FROM USFDA FOR SCO-088 FOR
TREATMENT OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA

Source text: http://bit.ly/2S7FcHG
Further company coverage:  SPRC.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sun Pharma Advanced Research

See all news